诺瑞特

Noratech is a Chinese biopharmaceutical company specializing in the development and manufacturing of complex long-acting injectable formulations, particularly microsphere-based drug delivery systems. The company focuses on high-barrier generic and innovative drugs in therapeutic areas such as endocrinology, psychiatry, and oncology. Noratech's core technology platform enables the controlled release of peptides and small molecules over weeks or months, improving patient compliance and therapeutic outcomes. With facilities in Beijing and Chengdu, the company has successfully advanced several programs through clinical development and into the commercial stage in the Chinese market. Their lead product, Octreotide Acetate Microspheres, has received regulatory approval, establishing the company as a leader in the domestic long-acting injection space.